A Softer Approach to Treating Hypertension
Scientists have developed a flexible 3D-printed artery implant that may offer a new way to treat high blood pressure without relying entirely on medication. The experimental device, created by researchers at Penn State, reduced blood pressure by more than 15% during early animal trials. The technology combines soft hydrogel materials with bioelectronics, allowing the implant to interact naturally with blood vessels inside the body.
Unlike traditional implants made from stiff metals or hard plastics, the new device is soft and stretchable. Researchers designed it to wrap gently around the carotid artery, one of the major blood vessels in the neck. Because the implant moves with the artery instead of resisting it, scientists believe it may reduce irritation and long-term tissue damage.
How the Implant Works
The device works by stimulating the body’s baroreflex system, which helps regulate blood pressure automatically. Tiny electrical pulses activate nerve endings located near the carotid artery. These signals then travel to the brain, prompting the body to lower blood pressure by relaxing blood vessels and adjusting heart activity.
To make the implant stay securely attached, researchers used a special adhesive hydrogel that bonds directly to living tissue without stitches. Laboratory tests showed the material could stretch to more than twice its original size before breaking, demonstrating the durability needed to survive the constant movement of arteries.
Promising Early Results
During animal testing, the implant successfully lowered blood pressure in most stimulation settings tested by the research team. Scientists also observed only mild inflammation around the implant site after two weeks, suggesting the soft material may be safer and more compatible with living tissue than conventional electrodes.
Researchers say the technology could eventually help patients with drug-resistant hypertension, a condition where medications fail to control blood pressure effectively. Although human trials are still some years away, the study highlights how 3D printing and bioelectronic medicine could reshape future cardiovascular treatments.
